2023 American Society of Anesthesiologists practice guidelines for monitoring and antagonism of neuromuscular blockade: a report by the American Society of …

SR Thilen, WA Weigel, MM Todd, RP Dutton… - …, 2023 - pubs.asahq.org
These practice guidelines provide evidence-based recommendations on the management
of neuromuscular monitoring and antagonism of neuromuscular blocking agents during and …

[HTML][HTML] Sugammadex administration in patients with end-stage renal disease: a narrative review with recommendations

SK Oh, BG Lim - Anesthesia and Pain Medicine, 2023 - synapse.koreamed.org
Due to unknown safety concerns, sugammadex should not be administered to patients with
end-stage renal disease (ESRD). However, because the supply of benzylisoquinolinium …

Effect of glycopyrrolate on the postoperative urine output of patients following kidney transplantation: a retrospective observational study

BS Koo, SY Park, YS Jang, YH Woo… - Journal of …, 2023 - journals.sagepub.com
Objectives To compare the urine output and estimated glomerular filtration rate (eGFR) of
patients postoperatively administered sugammadex or glycopyrrolate 7 days following …

Magnetic solid phase extraction coupled with LC-MS/MS methods for the simple extraction and rapid determination of sugammadex in human plasma

Y Wang, Y Qu, Y Jiang, Z Li, X Hou, L Yang… - Analytical …, 2024 - pubs.rsc.org
Sugammadex (SUG), fast reversal of neuromuscular blockade, is a novel antagonist of
neuromuscular blocking agents (NMBA). Rocuronium, one of NMBAs, is usually used to get …

Effects of sugammadex plus rocuronium vs neostigmine plus cisatracurium during renal transplantation on graft function: a retrospective, case-control study

M Vargas, P Buonanno, A Sica, E Sabatella… - Transplantation …, 2021 - Elsevier
Background Rocuronium can be used in patients with severe renal failure (creatinine
clearance< 30 mL/min), but the duration of muscle relaxation is longer and results in an …

[HTML][HTML] Impact on grafted kidney function of rocuronium-sugammadex vs cisatracurium-neostigmine strategy for neuromuscular block management. An Italian single …

M Carron, G Andreatta, E Pesenti, A De Cassai… - Perioperative …, 2022 - Springer
Background The impact of sugammadex in patients with end-stage renal disease
undergoing kidney transplantation is still far from being defined. The aim of the study is to …

[PDF][PDF] M. Carron1, G. Andreatta1, E. Pesenti1, A. De Cassai2, P. Feltracco1, F. Linassi3, M. Sergi2, C. Di Bella4, M. Di Bello4

F Neri, C Silvestre, L Furian, P Navalesi - 2022 - perioperativemedicinejournal …
Background: The impact of sugammadex in patients with end-stage renal disease
undergoing kidney transplantation is still far from being defined. The aim of the study is to …

Comparison of Bleeding Profiles of Sugammadex and Neostigmine in Orthotopic Liver Transplantation

H Liang, L White, RM Chadha… - Authorea …, 2021 - advance.sagepub.com
In the era of “fast-track'liver transplantation (LT), neuromuscular blockade (NMB) antagonists
such as neostigmine or sugammadex are used to achieve the restoration of neuromuscular …

Sugammadex Compared to Neostigmine for Reversal of Neuromuscular Block in Patients Undergoing Kidney Transplantation. A Retrospective Cohort, Case-Control …

M Carron, G Adreatta, E Pesenti, A De Cassai… - 2021 - researchsquare.com
Background: The impact of sugammadex in patients with end-stage renal disease
undergoing kidney transplantation is still far from being defined. The aim of the study is to …

Anästhesie für Patienten nach Transplantation abdomineller Organe

S Greve, T Palmaers - AINS-Anästhesiologie· Intensivmedizin …, 2020 - thieme-connect.com
Eine immer weiterentwickelte und erfolgreiche Transplantationsmedizin sorgt für eine große
Zahl an lebenden transplantierten Patienten. Ein anästhesiologisch tätiger Arzt muss damit …